(-)-epigallocatechin 3-gallate increases expression ISO WNT5A (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of WNT5A mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of WNT5A mRNA CTD PMID:22079256 (-)-gambogic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 gambogic acid results in decreased expression of WNT5A mRNA and gambogic acid results in decreased expression of WNT5A protein CTD PMID:33533530 1,1-dichloroethene decreases expression ISO Wnt5a (Mus musculus) 6480464 vinylidene chloride results in decreased expression of WNT5A mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO Wnt5a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of WNT5A mRNA CTD PMID:22206623 1,4-benzoquinone increases expression ISO WNT5A (Homo sapiens) 6480464 quinone results in increased expression of WNT5A mRNA CTD PMID:22960397 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of WNT5A mRNA CTD PMID:21058326 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of WNT5A mRNA CTD PMID:16551644 17beta-estradiol multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol decreases expression ISO WNT5A (Homo sapiens) 6480464 Estradiol results in decreased expression of WNT5A mRNA CTD PMID:31614463 and PMID:31646340 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of WNT5A mRNA CTD PMID:31119341 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of WNT5A mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO Wnt5a (Mus musculus) 6480464 Estradiol results in increased expression of WNT5A mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO WNT5A (Homo sapiens) 6480464 Estradiol results in increased expression of WNT5A mRNA CTD PMID:19619570 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO WNT5A (Homo sapiens) 6480464 2 more ... CTD PMID:22262711 2,3,7,8-tetrachlorodibenzodioxine decreases secretion ISO Wnt5a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased secretion of WNT5A protein CTD PMID:26572662 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT5A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Wnt5a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of WNT5A mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO WNT5A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT5A mRNA and Tetrachlorodibenzodioxin results in increased expression of WNT5A protein CTD PMID:19619570 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Wnt5a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT5A mRNA CTD PMID:17586704 and PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO WNT5A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT5A mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of WNT5A mRNA CTD PMID:19619570 2-hydroxypropanoic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of WNT5A mRNA CTD PMID:30851411 3',5'-cyclic AMP multiple interactions ISO WNT5A (Homo sapiens) 6480464 WNT5A protein affects the reaction [[Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] which results in increased expression of SOD2 mRNA] and WNT5A protein affects the reaction [Medroxyprogesterone Acetate results in increased abundance of Cyclic AMP] CTD PMID:20685861 3,3',4,4',5-pentachlorobiphenyl increases expression ISO WNT5A (Homo sapiens) 6480464 3 more ... CTD PMID:22262711 and PMID:35618242 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine increases expression ISO Wnt5a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of WNT5A mRNA CTD PMID:20188158 3,4-methylenedioxymethamphetamine affects methylation ISO Wnt5a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine affects the methylation of WNT5A promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO Wnt5a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of WNT5A mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol decreases expression ISO WNT5A (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of WNT5A mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol affects methylation ISO Wnt5a (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of WNT5A gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO Wnt5a (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of WNT5A exon CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO Wnt5a (Mus musculus) 6480464 Fenretinide results in decreased expression of WNT5A mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases expression ISO WNT5A (Homo sapiens) 6480464 Decitabine results in decreased expression of WNT5A mRNA and Decitabine results in decreased expression of WNT5A protein CTD PMID:30125549 5-azacytidine increases expression ISO WNT5A (Homo sapiens) 6480464 Azacitidine results in increased expression of WNT5A mRNA CTD PMID:20823114 5-fluorouracil increases expression ISO WNT5A (Homo sapiens) 6480464 Fluorouracil results in increased expression of WNT5A mRNA CTD PMID:31711903 5-fluorouracil multiple interactions EXP 150530464 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon] RGD 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of WNT5A mRNA CTD PMID:24780913 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of WNT5A mRNA CTD PMID:30047161 acetaldehyde affects expression ISO Wnt5a (Mus musculus) 6480464 Acetaldehyde affects the expression of WNT5A mRNA CTD PMID:22634333 acrolein multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WNT5A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WNT5A mRNA CTD PMID:32699268 aflatoxin B1 decreases expression ISO WNT5A (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of WNT5A mRNA CTD PMID:22100608 and PMID:27153756 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of WNT5A mRNA CTD PMID:18004065 aldehydo-D-glucose increases expression ISO WNT5A (Homo sapiens) 6480464 Glucose results in increased expression of WNT5A mRNA CTD PMID:29163160 aldehydo-D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 all-trans-retinoic acid decreases expression ISO Wnt5a (Mus musculus) 6480464 Tretinoin results in decreased expression of WNT5A mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] results in increased expression of WNT5A mRNA CTD PMID:31711903 all-trans-retinoic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 Tretinoin results in decreased expression of WNT5A mRNA CTD PMID:31711903 all-trans-retinoic acid increases expression ISO WNT5A (Homo sapiens) 6480464 Tretinoin results in increased expression of WNT5A mRNA CTD PMID:21934132 alpha-pinene multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WNT5A mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WNT5A mRNA CTD PMID:32699268 amitrole increases expression EXP 6480464 Amitrole results in increased expression of WNT5A mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of WNT5A mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO WNT5A (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of WNT5A mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO WNT5A (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of WNT5A mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO WNT5A (Homo sapiens) 6480464 arsenite results in increased expression of WNT5A mRNA CTD PMID:19061910 arsenite(3-) multiple interactions ISO WNT5A (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of WNT5A mRNA] CTD PMID:31646340 arsenite(3-) decreases expression ISO WNT5A (Homo sapiens) 6480464 arsenite results in decreased expression of WNT5A mRNA CTD PMID:31646340 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of WNT5A mRNA and Atrazine results in decreased expression of WNT5A protein CTD PMID:31187311 azoxystrobin decreases expression ISO WNT5A (Homo sapiens) 6480464 azoxystrobin results in decreased expression of WNT5A mRNA CTD PMID:33512557 benzo[a]pyrene increases expression ISO WNT5A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of WNT5A mRNA and Benzo(a)pyrene results in increased expression of WNT5A protein CTD PMID:20064835 and PMID:21802500 benzo[a]pyrene decreases methylation ISO WNT5A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of WNT5A 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO Wnt5a (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of WNT5A mRNA CTD PMID:22228805 beta-naphthoflavone increases expression ISO WNT5A (Homo sapiens) 6480464 beta-Naphthoflavone results in increased expression of WNT5A mRNA CTD PMID:32858204 bisphenol A increases expression ISO Wnt5a (Mus musculus) 6480464 bisphenol A results in increased expression of WNT5A mRNA CTD PMID:24465770 and PMID:35598803 bisphenol A multiple interactions ISO WNT5A (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WNT5A gene CTD PMID:31601247 bisphenol A decreases methylation ISO WNT5A (Homo sapiens) 6480464 bisphenol A results in decreased methylation of WNT5A gene CTD PMID:31601247 bisphenol A affects methylation ISO Wnt5a (Mus musculus) 6480464 bisphenol A affects the methylation of WNT5A promoter CTD PMID:27334623 bisphenol A decreases expression ISO WNT5A (Homo sapiens) 6480464 bisphenol A results in decreased expression of WNT5A mRNA CTD PMID:16029874 and PMID:27685785 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of WNT5A mRNA CTD PMID:25181051 and PMID:34947998 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of WNT5A mRNA CTD PMID:26496021 bisphenol F increases expression ISO Wnt5a (Mus musculus) 6480464 bisphenol F results in increased expression of WNT5A mRNA CTD PMID:30951980 bucladesine multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA CTD PMID:20823114 cadmium atom multiple interactions ISO WNT5A (Homo sapiens) 6480464 Cadmium inhibits the reaction [Fulvestrant results in increased expression of WNT5A mRNA] CTD PMID:31646340 cadmium atom multiple interactions ISO Wnt5a (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT5A mRNA CTD PMID:36114956 cadmium atom decreases expression ISO WNT5A (Homo sapiens) 6480464 Cadmium results in decreased expression of WNT5A mRNA CTD PMID:31646340 cadmium dichloride multiple interactions ISO Wnt5a (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT5A mRNA CTD PMID:36114956 calciol increases expression ISO Wnt5a (Mus musculus) 6480464 Cholecalciferol results in increased expression of WNT5A mRNA CTD PMID:17170073 calcitriol increases expression ISO WNT5A (Homo sapiens) 6480464 Calcitriol results in increased expression of WNT5A mRNA CTD PMID:16002434 calcium atom increases expression ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased expression of WNT5A mRNA CTD PMID:24658506 calcium atom multiple interactions ISO WNT5A (Homo sapiens) 6480464 CASR mutant form inhibits the reaction [Calcium results in increased expression of WNT5A protein] more ... CTD PMID:24658506 calcium atom increases secretion ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased secretion of WNT5A protein CTD PMID:24658506 calcium(0) increases expression ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased expression of WNT5A mRNA CTD PMID:24658506 calcium(0) increases secretion ISO WNT5A (Homo sapiens) 6480464 Calcium results in increased secretion of WNT5A protein CTD PMID:24658506 calcium(0) multiple interactions ISO WNT5A (Homo sapiens) 6480464 CASR mutant form inhibits the reaction [Calcium results in increased expression of WNT5A protein] more ... CTD PMID:24658506 cannabidiol multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of WNT5A mRNA CTD PMID:30096889 carbon nanotube increases expression ISO Wnt5a (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of WNT5A mRNA CTD PMID:25554681 carmustine affects response to substance ISO WNT5A (Homo sapiens) 6480464 WNT5A mRNA affects the susceptibility to Carmustine CTD PMID:16365179 casticin decreases expression ISO WNT5A (Homo sapiens) 6480464 casticin results in decreased expression of WNT5A mRNA CTD PMID:27862857 CHIR 99021 increases expression ISO WNT5A (Homo sapiens) 6480464 Chir 99021 results in increased expression of WNT5A mRNA CTD PMID:31711903 CHIR 99021 multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:31711903 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of WNT5A mRNA CTD PMID:18502319 chromium(6+) affects expression ISO WNT5A (Homo sapiens) 6480464 chromium hexavalent ion affects the expression of WNT5A mRNA CTD PMID:30690063 cisplatin multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of WNT5A mRNA and [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of WNT5A mRNA CTD PMID:27392435 and PMID:30871063 clofibrate increases expression ISO Wnt5a (Mus musculus) 6480464 Clofibrate results in increased expression of WNT5A mRNA CTD PMID:23811191 cocaine multiple interactions ISO Wnt5a (Mus musculus) 6480464 HDAC5 affects the reaction [Cocaine affects the expression of WNT5A mRNA] CTD PMID:17988634 copper atom multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of WNT5A mRNA CTD PMID:30911355 and PMID:31162603 copper atom decreases expression EXP 6480464 Copper results in decreased expression of WNT5A mRNA CTD PMID:30556269 copper(0) multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of WNT5A mRNA CTD PMID:30911355 and PMID:31162603 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of WNT5A mRNA CTD PMID:30556269 cyclosporin A decreases expression ISO WNT5A (Homo sapiens) 6480464 Cyclosporine results in decreased expression of WNT5A mRNA CTD PMID:20106945 and PMID:22147139 cyclosporin A increases expression ISO WNT5A (Homo sapiens) 6480464 Cyclosporine results in increased expression of WNT5A mRNA CTD PMID:27989131 cyfluthrin increases expression ISO WNT5A (Homo sapiens) 6480464 cyfluthrin results in increased expression of WNT5A mRNA CTD PMID:32028016 cypermethrin increases expression ISO WNT5A (Homo sapiens) 6480464 cypermethrin results in increased expression of WNT5A mRNA CTD PMID:32028016 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of WNT5A mRNA CTD PMID:18004065 D-glucose increases expression ISO WNT5A (Homo sapiens) 6480464 Glucose results in increased expression of WNT5A mRNA CTD PMID:29163160 D-glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of WNT5A mRNA CTD PMID:23914054 deguelin decreases expression ISO WNT5A (Homo sapiens) 6480464 deguelin results in decreased expression of WNT5A mRNA CTD PMID:33512557 diazinon affects expression EXP 6480464 Diazinon affects the expression of WNT5A mRNA CTD PMID:18502319 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of WNT5A mRNA CTD PMID:19130878 dibutyl phthalate decreases expression ISO Wnt5a (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of WNT5A mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of WNT5A mRNA CTD PMID:25213187 dieldrin decreases expression EXP 6480464 Dieldrin results in decreased expression of WNT5A mRNA CTD PMID:19130878 diethylstilbestrol multiple interactions ISO Wnt5a (Mus musculus) 6480464 WNT5A protein affects the reaction [Diethylstilbestrol results in decreased expression of HOXA10 mRNA] more ... CTD PMID:15073149 diethylstilbestrol increases expression ISO Wnt5a (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of WNT5A mRNA CTD PMID:15070830 and PMID:15073149 diuron increases expression EXP 6480464 Diuron results in increased expression of WNT5A mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO Wnt5a (Mus musculus) 6480464 Doxorubicin results in decreased expression of WNT5A mRNA CTD PMID:25896364 doxorubicin decreases expression ISO WNT5A (Homo sapiens) 6480464 Doxorubicin results in decreased expression of WNT5A mRNA CTD PMID:29803840 erastin multiple interactions ISO Wnt5a (Mus musculus) 6480464 erastin promotes the reaction [Silicon Dioxide results in increased expression of WNT5A protein] CTD PMID:37075931 erastin increases expression ISO Wnt5a (Mus musculus) 6480464 erastin results in increased expression of WNT5A protein CTD PMID:37075931 ferrostatin-1 multiple interactions ISO Wnt5a (Mus musculus) 6480464 ferrostatin-1 inhibits the reaction [Silicon Dioxide results in increased expression of WNT5A protein] CTD PMID:37075931 fluoranthene multiple interactions ISO Wnt5a (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT5A mRNA CTD PMID:28329830 flusilazole affects expression ISO Wnt5a (Mus musculus) 6480464 flusilazole affects the expression of WNT5A mRNA CTD PMID:22634333 flusilazole decreases expression EXP 6480464 flusilazole results in decreased expression of WNT5A mRNA CTD PMID:28263823 folic acid affects expression ISO WNT5A (Homo sapiens) 6480464 Folic Acid affects the expression of WNT5A mRNA CTD PMID:17320366 fulvestrant multiple interactions ISO WNT5A (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WNT5A gene more ... CTD PMID:31601247 and PMID:31646340 fulvestrant increases expression ISO WNT5A (Homo sapiens) 6480464 Fulvestrant results in increased expression of WNT5A mRNA CTD PMID:31646340 gemcitabine decreases expression ISO WNT5A (Homo sapiens) 6480464 Gemcitabine results in decreased expression of WNT5A mRNA CTD PMID:17039268 genistein decreases expression EXP 6480464 Genistein results in decreased expression of WNT5A mRNA CTD PMID:17341692 genistein increases expression ISO Wnt5a (Mus musculus) 6480464 Genistein results in increased expression of WNT5A mRNA CTD PMID:21810550 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of WNT5A mRNA CTD PMID:33387578 glucose decreases expression EXP 6480464 Glucose results in decreased expression of WNT5A mRNA CTD PMID:18004065 glucose increases expression ISO WNT5A (Homo sapiens) 6480464 Glucose results in increased expression of WNT5A mRNA CTD PMID:29163160 glucose multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 glyphosate affects expression EXP 6480464 glyphosate affects the expression of WNT5A protein CTD PMID:28780397 glyphosate increases expression ISO WNT5A (Homo sapiens) 6480464 glyphosate results in increased expression of WNT5A mRNA CTD PMID:31874349 glyphosate decreases response to substance EXP 6480464 WNT5A protein results in decreased susceptibility to glyphosate CTD PMID:26688330 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of WNT5A mRNA and glyphosate results in decreased expression of WNT5A protein CTD PMID:26688330 homocysteine decreases expression ISO WNT5A (Homo sapiens) 6480464 Homocysteine results in decreased expression of WNT5A mRNA CTD PMID:17320366 hydrogen peroxide affects expression ISO WNT5A (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of WNT5A mRNA CTD PMID:20044591 hydroquinone increases expression ISO WNT5A (Homo sapiens) 6480464 hydroquinone results in increased expression of WNT5A mRNA CTD PMID:22960397 iron dichloride decreases expression ISO WNT5A (Homo sapiens) 6480464 ferrous chloride results in decreased expression of WNT5A mRNA CTD PMID:35984750 isotretinoin decreases expression ISO WNT5A (Homo sapiens) 6480464 Isotretinoin results in decreased expression of WNT5A mRNA CTD PMID:31711903 KN-93 multiple interactions ISO Wnt5a (Mus musculus) 6480464 KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of WNT5A protein] CTD PMID:37075931 lipopolysaccharide multiple interactions ISO WNT5A (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:32048402 and PMID:35811015 lipopolysaccharide increases expression ISO WNT5A (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of WNT5A mRNA and Lipopolysaccharides results in increased expression of WNT5A protein CTD PMID:32048402 and PMID:35811015 loliolide increases expression ISO WNT5A (Homo sapiens) 6480464 loliolide results in increased expression of WNT5A mRNA CTD PMID:31601058 loliolide multiple interactions ISO WNT5A (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [loliolide results in increased expression of WNT5A mRNA] CTD PMID:31601058 LY294002 multiple interactions ISO WNT5A (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [loliolide results in increased expression of WNT5A mRNA] CTD PMID:31601058 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of WNT5A mRNA and [Paraquat co-treated with Maneb] results in increased expression of WNT5A protein CTD PMID:29152652 medroxyprogesterone acetate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of WNT5A mRNA more ... CTD PMID:20685861 and PMID:20823114 medroxyprogesterone acetate increases expression ISO WNT5A (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of WNT5A mRNA CTD PMID:20685861 mercury dibromide increases expression ISO WNT5A (Homo sapiens) 6480464 mercuric bromide results in increased expression of WNT5A mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 methimazole increases expression EXP 6480464 Methimazole results in increased expression of WNT5A mRNA CTD PMID:30047161 methotrexate increases expression ISO WNT5A (Homo sapiens) 6480464 Methotrexate results in increased expression of WNT5A mRNA CTD PMID:17320366 methylmercury chloride decreases expression ISO WNT5A (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of WNT5A mRNA CTD PMID:28001369 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of WNT5A mRNA CTD PMID:34740672 mifepristone increases expression ISO WNT5A (Homo sapiens) 6480464 Mifepristone results in increased expression of WNT5A mRNA CTD PMID:17584828 mitomycin C affects response to substance ISO WNT5A (Homo sapiens) 6480464 WNT5A protein affects the susceptibility to Mitomycin CTD PMID:16217747 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of WNT5A mRNA CTD PMID:17341692 N-methyl-N-nitrosourea increases expression EXP 150530464 N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon RGD nickel atom increases expression EXP 6480464 Nickel results in increased expression of WNT5A mRNA CTD PMID:19130878 nickel sulfate increases expression ISO WNT5A (Homo sapiens) 6480464 nickel sulfate results in increased expression of WNT5A mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of WNT5A mRNA and nitrofen results in increased expression of WNT5A protein CTD PMID:20006014 Nor-9-carboxy-delta9-THC multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of WNT5A gene CTD PMID:30521419 ozone multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WNT5A mRNA more ... CTD PMID:32699268 panobinostat multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WNT5A mRNA CTD PMID:27188386 panobinostat decreases expression ISO WNT5A (Homo sapiens) 6480464 panobinostat results in decreased expression of WNT5A mRNA CTD PMID:26272509 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of WNT5A mRNA CTD PMID:33387578 paracetamol decreases expression ISO Wnt5a (Mus musculus) 6480464 Acetaminophen results in decreased expression of WNT5A mRNA CTD PMID:37179516 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in increased expression of WNT5A mRNA and [Paraquat co-treated with Maneb] results in increased expression of WNT5A protein CTD PMID:29152652 perfluorohexanesulfonic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in decreased expression of WNT5A mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases expression ISO WNT5A (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of WNT5A mRNA CTD PMID:25812627 perfluorooctanoic acid increases expression ISO WNT5A (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of WNT5A mRNA CTD PMID:25812627 phenobarbital multiple interactions ISO Wnt5a (Mus musculus) 6480464 NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of WNT5A mRNA] CTD PMID:19482888 phenobarbital affects expression ISO WNT5A (Homo sapiens) 6480464 Phenobarbital affects the expression of WNT5A mRNA CTD PMID:19159669 phenobarbital increases expression ISO Wnt5a (Mus musculus) 6480464 Phenobarbital results in increased expression of WNT5A mRNA CTD PMID:19482888 phenylmercury acetate increases expression ISO WNT5A (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of WNT5A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 phenytoin increases expression ISO WNT5A (Homo sapiens) 6480464 Phenytoin results in increased expression of WNT5A mRNA CTD PMID:31711903 picoxystrobin decreases expression ISO WNT5A (Homo sapiens) 6480464 picoxystrobin results in decreased expression of WNT5A mRNA CTD PMID:33512557 pirinixic acid increases expression ISO Wnt5a (Mus musculus) 6480464 pirinixic acid results in increased expression of WNT5A mRNA CTD PMID:18301758 pirinixic acid multiple interactions ISO WNT5A (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WNT5A mRNA CTD PMID:19710929 potassium chromate decreases expression ISO WNT5A (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of WNT5A mRNA CTD PMID:22079256 potassium chromate increases expression ISO WNT5A (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of WNT5A mRNA CTD PMID:22714537 potassium chromate multiple interactions ISO WNT5A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of WNT5A mRNA CTD PMID:22079256 progesterone multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of WNT5A mRNA CTD PMID:20660070 quercetin multiple interactions EXP 150530464 Quercetin inhibits the reaction [N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon] RGD rac-lactic acid decreases expression ISO WNT5A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of WNT5A mRNA CTD PMID:30851411 raloxifene multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of WNT5A mRNA CTD PMID:19059307 resveratrol decreases expression ISO WNT5A (Homo sapiens) 6480464 resveratrol results in decreased expression of WNT5A mRNA and resveratrol results in decreased expression of WNT5A protein CTD PMID:25061499 resveratrol multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of WNT5A mRNA CTD PMID:23557933 rotenone decreases expression ISO WNT5A (Homo sapiens) 6480464 Rotenone results in decreased expression of WNT5A mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO WNT5A (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Chir 99021 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:31711903 SB 431542 decreases expression ISO WNT5A (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of WNT5A protein CTD PMID:19901340 silicon dioxide decreases expression ISO WNT5A (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of WNT5A mRNA more ... CTD PMID:23806026 more ... silicon dioxide increases expression ISO Wnt5a (Mus musculus) 6480464 Silicon Dioxide results in increased expression of WNT5A protein CTD PMID:37075931 silicon dioxide multiple interactions ISO Wnt5a (Mus musculus) 6480464 erastin promotes the reaction [Silicon Dioxide results in increased expression of WNT5A protein] more ... CTD PMID:37075931 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of WNT5A mRNA CTD PMID:32721576 simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT5A mRNA] CTD PMID:18004065 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of WNT5A mRNA and Simvastatin results in increased expression of WNT5A protein CTD PMID:18004065 and PMID:19968183 sodium arsenate increases expression ISO Wnt5a (Mus musculus) 6480464 sodium arsenate results in increased expression of WNT5A mRNA CTD PMID:21795629 sodium arsenite decreases expression ISO WNT5A (Homo sapiens) 6480464 sodium arsenite results in decreased expression of WNT5A mRNA CTD PMID:12679051 sodium arsenite decreases expression ISO Wnt5a (Mus musculus) 6480464 sodium arsenite results in decreased expression of WNT5A mRNA CTD PMID:36209798 sodium arsenite increases expression ISO WNT5A (Homo sapiens) 6480464 sodium arsenite results in increased expression of WNT5A mRNA CTD PMID:20886546 and PMID:34032870 Soman decreases expression EXP 6480464 Soman results in decreased expression of WNT5A mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of WNT5A mRNA CTD PMID:30047161 sunitinib decreases expression ISO WNT5A (Homo sapiens) 6480464 Sunitinib results in decreased expression of WNT5A mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO WNT5A (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of WNT5A mRNA CTD PMID:19059307 temozolomide affects response to substance ISO WNT5A (Homo sapiens) 6480464 WNT5A mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide decreases expression ISO WNT5A (Homo sapiens) 6480464 Temozolomide results in decreased expression of WNT5A mRNA CTD PMID:31758290 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of WNT5A mRNA CTD PMID:16780995 tributylstannane decreases expression ISO WNT5A (Homo sapiens) 6480464 tributyltin results in decreased expression of WNT5A mRNA CTD PMID:28011154 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of WNT5A mRNA CTD PMID:33387578 trichostatin A decreases expression ISO WNT5A (Homo sapiens) 6480464 trichostatin A results in decreased expression of WNT5A mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 trichostatin A increases expression ISO WNT5A (Homo sapiens) 6480464 trichostatin A results in increased expression of WNT5A mRNA CTD PMID:24935251 and PMID:26272509 troglitazone increases expression ISO WNT5A (Homo sapiens) 6480464 troglitazone results in increased expression of WNT5A mRNA CTD PMID:19140230 tunicamycin increases expression ISO Wnt5a (Mus musculus) 6480464 Tunicamycin results in increased expression of WNT5A mRNA CTD PMID:17127020 tunicamycin decreases expression ISO WNT5A (Homo sapiens) 6480464 Tunicamycin results in decreased expression of WNT5A mRNA CTD PMID:29453283 valproic acid affects expression ISO Wnt5a (Mus musculus) 6480464 Valproic Acid affects the expression of WNT5A mRNA CTD PMID:17292431 valproic acid increases expression ISO WNT5A (Homo sapiens) 6480464 Valproic Acid results in increased expression of WNT5A mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO WNT5A (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT5A mRNA CTD PMID:27188386 zoledronic acid increases expression ISO WNT5A (Homo sapiens) 6480464 zoledronic acid results in increased expression of WNT5A mRNA CTD PMID:24714768